NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Athira Pharma Inc (NASDAQ: ATHA)
ATHA Technical Analysis
5
As on 9th Jun 2023 ATHA STOCK Price closed @ 3.27 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.19 & Strong Sell for SHORT-TERM with Stoploss of 10.79 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATHASTOCK Price
Open | 3.49 | Change | Price | % |
High | 3.52 | 1 Day | -0.24 | -6.84 |
Low | 3.25 | 1 Week | 0.64 | 24.33 |
Close | 3.27 | 1 Month | 0.49 | 17.63 |
Volume | 231318 | 1 Year | -9.02 | -73.39 |
52 Week High 13.51 | 52 Week Low 2.26 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
ATHA Daily Charts |
ATHA Intraday Charts |
Whats New @ Bazaartrend |
ATHA Free Analysis |
|
ATHA Important Levels Intraday
RESISTANCE | 3.79 |
RESISTANCE | 3.62 |
RESISTANCE | 3.52 |
RESISTANCE | 3.42 |
SUPPORT | 3.12 |
SUPPORT | 3.02 |
SUPPORT | 2.92 |
SUPPORT | 2.75 |
ATHA Forecast April 2024
4th UP Forecast | 12.13 |
3rd UP Forecast | 9.29 |
2nd UP Forecast | 7.53 |
1st UP Forecast | 5.78 |
1st DOWN Forecast | 0.76 |
2nd DOWN Forecast | -0.99 |
3rd DOWN Forecast | -2.75 |
4th DOWN Forecast | -5.59 |
ATHA Weekly Forecast
4th UP Forecast | 5.27 |
3rd UP Forecast | 4.63 |
2nd UP Forecast | 4.23 |
1st UP Forecast | 3.84 |
1st DOWN Forecast | 2.70 |
2nd DOWN Forecast | 2.31 |
3rd DOWN Forecast | 1.91 |
4th DOWN Forecast | 1.27 |
ATHA Forecast2024
4th UP Forecast | 26.39 |
3rd UP Forecast | 18.98 |
2nd UP Forecast | 14.39 |
1st UP Forecast | 9.81 |
1st DOWN Forecast | -3.27 |
2nd DOWN Forecast | -7.85 |
3rd DOWN Forecast | -12.44 |
4th DOWN Forecast | -19.85 |
Athira Pharma Inc ( NASDAQ USA Symbol : ATHA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATHA Other Details
Segment | EQ | |
Market Capital | 453145184.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
ATHA Address
ATHA Latest News
ATHA Business Profile
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and stop neurodegradation. Its lead product candidate is ATH-1017, a blood brain barrier-penetrating, small hepatocyte growth factor/MET activator that is in LIFT-AD Phase II/III and ACT-AD Phase II clinical trials for the treatment of mild-to-moderate Alzheimer's disease, as well as in clinical development for Parkinson's disease. The company also develops product candidates, which are in preclinical stage, including ATH-1019/ATH-1020 for neuropsychiatric conditions; and ATH-1018 for peripheral nervous system disorders, such as neuropathy. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington. Address: 18706 North Creek Parkway, Bothell, WA, United States, 98011-2141
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service